Evidence map›Paper›PMID 30975779›Full record

ArticleBMJ case reports2019

Posaconazole in the treatment of refractory

Mariana Almeida Oliveira, Analia Carmo, Andreia Rosa, Joaquim Murta

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Voriconazole-resistantMedical mycology case reports · 2026
    Article
  3. Article
  4. Article
  5. AggressiveJournal of fungi (Basel, Switzerland) · 2025
    Article
  6. World journal of clinical cases · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. [Purpureocillium lilacinum : Atypical pathogen of mycotic keratitis in an immunocompetent patient].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2022
    Article
  11. First Report of a Case of Ocular Infection Caused byPathogens (Basel, Switzerland) · 2021
    Article
  12. Taiwan journal of ophthalmology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Mariana Almeida OliveiraDepartment of Ophthalmology, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal.
Analia CarmoClinical Pathology, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal.
Andreia RosaDepartment of Ophthalmology, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal.
Joaquim MurtaDepartment of Ophthalmology, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal.
Hospitais da Universidade de Coimbra · PTUniversity of Coimbra · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case of a 41-year-old woman, wearer of contact lenses who was presented to the emergency room with a 2-month history of pain and red eye. She presented with a severe keratitis refractory to quinolones, fortified antibiotics and clotrimazole. Due to the risk of perforation, a tectonic penetrating keratoplasty (PK) was performed. Clinical signs of keratitis recurrence were observed and cultures were positive for

Indexed as

Administration, OralAdultAntifungal AgentsDiagnosis, DifferentialEye Infections, FungalFemaleHumansKeratitisKeratoplasty, PenetratingPaecilomycesRecurrenceTriazolesAntifungal AgentsposaconazoleTriazolesanterior chamberdrugs: infectious diseaseseyetransplantationunwanted effects/adverse reactions

Identifiers

PMID30975779
PMCPMC6505977
OpenAlexW2938062108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.